DMPK

Allometric Scaling in Pharmacokinetics: From Animal to Human

Pharazi.ai TeamMarch 22, 20268 min read

Bridging the Mammalian Gap

Allometric scaling is the mathematical framework that translates PK data from preclinical species to human predictions, enabling safe First-In-Human (FIH) dose estimation.

Because all mammals share conserved organ architecture, physiological rates predictably scale with body mass in a non-linear fashion.

The Fundamental Allometric Equation

Y = aim es W^{b}

Where:

$Y$ = PK parameter being estimated (CL, Vd, etc.)
$W$ = Body weight (kg)
$a$ = Allometric coefficient (drug-specific constant)
$b$ = Allometric exponent (the power law)

Logarithmic transformation yields a linear equation:

lo g (Y) = lo g (a) + b \cdot lo g (W)

Accepted Exponents for PK Parameters

Volume of Distribution ( $V_{ss}$ )

Tissue mass scales nearly 1:1 with body mass (isometric).

Example: If a 10 kg dog has

V_{d} = 20 e x t L

(2 L/kg), allometric scaling estimates a 70 kg human at ~140 L.

Clearance ( $C L$ )

Metabolic engines do NOT scale linearly — smaller mammals clear drugs much faster per kg.

Simple linear scaling (1 mg/kg in mouse → 1 mg/kg in human) inevitably results in toxic overdosing in human trials.

Half-Life ( $t_{1/2}$ )

Proportional to Volume/Clearance = 1.0 - 0.75 = 0.25.

Biological clocks tick slower in larger mammals — half-lives predictably extend.

The Mahmood Criteria (Rule of Exponents)

If the derived clearance exponent breaks the expected range, allometric scaling may be invalid.

Exponent Range	Action
0.55–0.71	Simple allometry works well
0.71–1.0	Requires MLP or $f_{u}$ correction
> 1.0	Allometric scaling is invalid — dangerous guesswork

Modern Hybrid Approaches

The IVIVE-Allometry Hybrid fuses physiological scaling (blood flow limits) with in vitro human microsomal turnover data — ensuring human predictions rely on actual human protein mechanics.

Try It on Pharazi.ai

Use the Allometric Scaling Calculator to run multi-species regressions and flag toxic scaling errors.

References

Mahmood I. J Pharm Sci. 1996;85:411–414.
Boxenbaum H. J Pharmacokinet Biopharm. 1982;10:201–227.

allometric scalingDMPKclearancevolume of distributionpreclinicaltranslational PK

DMPK

IVIVE: Predicting Human Clearance from In Vitro Data

A comprehensive deep dive into In Vitro-In Vivo Extrapolation (IVIVE), utilizing the well-stirred model, microsomal binding, and physiological scaling.

All articles